ClinicalTrials.Veeva

Menu
K

Kaohsiung Veterans General Hospital | Department of Allergy, Immunology and Rheumatology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SHJ002
TAK-279
Hydroxyurea
PF-06700841
HZN-1116
Ropeginterferon Alfa-2b
Obexelimab
Sisunatovir
P1101
Interferon

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 23 total trials
Locations recently updated

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

The purpose of this study is to measure the efficacy and safety of HZN-1116 in participants with Sjogren's syndrome (SS).

Enrolling
Sjogren's Syndrome
Drug: HZN-1116
Drug: Placebo

The main aim of this study is to show how well TAK-279 reduces the skin plaques compared to placebo, in participants with moderate-to-severe plaque p...

Active, not recruiting
Plaque Psoriasis
Drug: Placebo
Drug: Apremilast

This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).

Enrolling
Systemic Lupus Erythematosus
Drug: Placebo
Drug: Obexelimab
Locations recently updated

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...

Enrolling
Plaque Psoriasis
Drug: TAK-279

This is a Phase 3 open-label, multicenter, randomized, active-controlled study designed to compare the efficacy and safety and tolerability of P1101...

Active, not recruiting
Essential Thrombocythemia
Drug: Anagrelide
Biological: Ropeginterferon alfa-2b

Trial sponsors

K
Pfizer logo
Amgen logo
Takeda logo
A
B
D
Moderna logo
O
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems